287
Views
2
CrossRef citations to date
0
Altmetric
Review

Stem cell and tissue engineering approaches in pressure ulcer treatment

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon

References

  • Edsberg LE, Black JM, Goldberg M, McNichol L, Moore L, Sieggreen M. Revised national pressure ulcer advisory panel pressure injury staging system: revised pressure injury staging system. J Wound Ostomy Continence Nurs 2016;43(6):585–97. doi:10.1097/WON.0000000000000281.
  • Peirce SM, Skalak TC, Rodeheaver GT. Ischemia-reperfusion injury in chronic pressure ulcer formation: a skin model in the rat. Wound Repair Regen 2000;8(1):68–76. doi:10.1046/j.1524-475x.2000.00068.x.
  • Mervis JS, Phillips TJ. Pressure ulcers: pathophysiology, epidemiology, risk factors, and presentation. J Am Acad Dermatol 2019;81(4):881–90. doi:10.1016/j.jaad.2018.12.069.
  • Anthony D, Alosoumi D, Safari R. Prevalence of pressure ulcers in long-term care: a global review. J Wound Care 2019;28(11):702–9. doi:10.12968/jowc.2019.28.11.702.
  • Shiferaw WS, Akalu TY, Mulugeta H, Aynalem YA. The global burden of pressure ulcers among patients with spinal cord injury: a systematic review and meta-analysis. BMC Musculoskelet Disord 2020;21(1):334. Published 2020 May 29. doi:10.1186/s12891-020-03369-0
  • Zakrasek EC, Creasey G, Crew JD. Pressure ulcers in people with spinal cord injury in developing nations. Spinal Cord 2015;53(1):7–13. doi:10.1038/sc.2014.179.
  • Spilsbury K, Nelson A, Cullum N, Iglesias C, Nixon J, Mason S. Pressure ulcers and their treatment and effects on quality of life: hospital inpatient perspectives. J Adv Nurs 2007;57(5):494–504. doi:10.1111/j.1365-2648.2006.04140.x.
  • Lyder CH, Wang Y, Metersky M, Curry M, Kliman R, Verzier NR, et al. Hospital-acquired pressure ulcers: results from the national medicare patient safety monitoring system study. J Am Geriatr Soc 2012 Sep;60(9):1603–8. doi:10.1111/j.1532-5415.2012.04106.x.
  • Nussbaum SR, Carter MJ, Fife CE, DaVanzo J, Haught R, Nusgart M, et al. An economic evaluation of the impact, cost, and medicare policy implications of chronic nonhealing wounds. Value Health 2018;21(1):27–32. doi:10.1016/j.jval.2017.07.007.
  • Dealey C, Posnett J, Walker A. The cost of pressure ulcers in the United Kingdom. J Wound Care 2012;21(6):261–6. doi:10.12968/jowc.2012.21.6.261.
  • Demarré L, Van Lancker A, Van Hecke A, Verhaeghe S, Grypdonck M, Lemey J, et al. The cost of prevention and treatment of pressure ulcers: A systematic review. Int J Nurs Stud 2015 Nov;52(11):1754–74. doi:10.1016/j.ijnurstu.2015.06.006. Epub 2015 Jun 25. PMID: 26231383.
  • Lechner A, Kottner J, Coleman S, Muir D, Beeckman D, Chaboyer W, et al. Outcomes for pressure ulcer trials (OUTPUTs) project: review and classification of outcomes reported in pressure ulcer prevention research [published online ahead of print, 2020 Jun 8]. Br J Dermatol. 2020. doi:10.1111/bjd.19304
  • Mondragon N, Zito PM. Pressure injury. In: Statpearls. Treasure Island (FL): StatPearls Publishing; 2020. PMID: 32491791.
  • Wong JK, Amin K, Dumville JC. Reconstructive surgery for treating pressure ulcers. Cochrane Database Syst Rev. 2016;12(12):CD012032. Published 2016 Dec 6. doi:10.1002/14651858. CD012032.pub2
  • Lindqvist EK, Sommar P, Stenius M, Lagergren JF. Complications after pressure ulcer surgery – a study of 118 operations in spinal cord injured patients. J Plast Surg Hand Surg 2020;54(3):145–50. doi:10.1080/2000656X.2020.1720700.
  • Yang LL, Xiao ZL, An PJ, Yan HJ, Li Q. Association between pressure ulcers and the risk of postoperative infections in male adults with spinal cord injury [published online ahead of print, 2020 Jun 1]. Br J Neurosurg 2020: 1–4. doi:10.1080/02688697.2020.1769552.
  • Stadler I, Zhang RY, Oskoui P, Whittaker MS, Lanzafame RJ. Development of a simple, noninvasive, clinically relevant model of pressure ulcers in the mouse. J Invest Surg 2004;17(4):221–7. doi:10.1080/08941930490472046.
  • Motegi SI, Sekiguchi A, Uchiyama A, Uehara A, Fujiwara C, Yamazaki S, et al. Protective effect of mesenchymal stem cells on the pressure ulcer formation by the regulation of oxidative and endoplasmic reticulum stress. Sci Rep 2017;7(1):17186. Published 2017 Dec 7. doi:10.1038/s41598-017-17630-5
  • Strong AL, Bowles AC, MacCrimmon CP, Frazier TP, Lee SJ, Wu X, et al. Adipose stromal cells repair pressure ulcers in both young and elderly mice: potential role of adipogenesis in skin repair. Stem Cells Transl Med 2015;4(6):632–42. doi:10.5966/sctm.2014-0235.
  • Bukowska J, Alarcon Uquillas A, Wu X, Frazier T, Walendzik K, Vanek M, et al. Safety and efficacy of human adipose-derived stromal/stem cell therapy in an immunocompetent murine pressure ulcer model. Stem CellS Dev 2020A;29(7):440–51. doi:10.1089/scd.2019.0244.
  • Bukowska J, Alarcon Uquillas A, Wu X, Frazier T, Walendzik K, Vanek M, et al. Safety of human adipose stromal vascular fraction cells isolated with a closed system device in an immunocompetent murine pressure ulcer model. Stem Cells Dev 2020B;29(7):452–61. doi:10.1089/scd.2019.0245.
  • Xiao S, Liu Z, Yao Y, Wei ZR, Wang D, Deng C. Diabetic human adipose-derived stem cells accelerate pressure ulcer healing by inducing angiogenesis and neurogenesis. Stem Cells Dev 2019;28(5):319–28. doi:10.1089/scd.2018.0245.
  • Azari O, Babaei H, Derakhshanfar A, Nematollahi-Mahani SN, Poursahebi R, Moshrefi M. Effects of transplanted mesenchymal stem cells isolated from Wharton’s jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation. Vet Res Commun 2011;35(4):211–22. doi:10.1007/s11259-011-9464-z-.
  • Yoon D, Yoon D, Sim H, Hwang I, Lee JS, Chun W. Accelerated wound healing by fibroblasts differentiated from human embryonic stem cell-derived mesenchymal stem cells in a pressure ulcer animal model. Stem Cells Int. 2018;2018:4789568. Published 2018 Dec 30. doi:10.1155/2018/4789568
  • Sarasúa JG, López SP, Viejo MA, Basterrechea MP, Rodríguez AF, Gutiérrez AF, et al. Treatment of pressure ulcers with autologous bone marrow nuclear cells in patients with spinal cord injury. J Spinal Cord Med 2011;34(3):301–7. doi:10.1179/2045772311Y.0000000010.
  • Vacanti CA. The history of tissue engineering. J Cell Mol Med 2006;10(3):569–76. doi:10.1111/j.1582-4934.2006.tb00421.x.
  • Domaszewska-Szostek A, Krzyżanowska M, Siemionow M. Cell-based therapies for chronic wounds tested in clinical studies: review. Ann Plast Surg 2019;83(6):e96–e109. doi:10.1097/SAP.0000000000001947.
  • Ucare. Bioengineering skin substitutes-medical policy 2016; Ucare medical policy-policy number: 2016M0011B; Ucare: Minneapolis, MN, USA, 2016.
  • Widjaja W, Tan J, Maitz PKM. Efficacy of dermal substitute on deep dermal to full thickness burn injury: a systematic review. ANZ J Surg 2017;87(6):446–52. doi:10.1111/ans.13920.
  • Dieckmann C, Renner R, Milkova L, Simon JC. Regenerative medicine in dermatology: biomaterials, tissue engineering, stem cells, gene transfer and beyond. Exp Dermatol 2010;19(8):697–706. doi:10.1111/j.1600-0625.2010.01087.x.
  • van der Veen VC, van der Wal MB, van Leeuwen MC, Ulrich MM, Middelkoop E. Biological background of dermal substitutes. Burns 2010;36(3):305–21. doi:10.1016/j.burns.2009.07.012.
  • Wong VW, Gurtner GC. Tissue engineering for the management of chronic wounds: current concepts and future perspectives. Exp Dermatol 2012;21(10):729–34. doi:10.1111/j.1600-0625.2012.01542.x.
  • Nour S, Baheiraei N, Imani R, Khodaei M, Alizadeh A, Rabiee N, Moazzeni SM. A review of accelerated wound healing approaches: biomaterial- assisted tissue remodeling. J Mater Sci Mater Med. 2019;30(10):120. Published 2019 Oct 19. doi:10.1007/s10856-019-6319-6.
  • Chen FM, Liu X. Advancing biomaterials of human origin for tissue engineering. Prog Polym Sci 2016;53:86–168. doi:10.1016/j.progpolymsci.2015.02.004.
  • Yannas IV. Biomaterials science: an introduction to materials in medicine, 2nd ed. (Ed: BD Ratner). USA: Elsevier Academic Press; 2004. p. 127–36. ISBN: 9780080470368.
  • Ichioka S, Ohura N, Sekiya N, Shibata M, Nakatsuka T. Regenerative surgery for sacral pressure ulcers using collagen matrix substitute dermis (artificial dermis). Ann Plast Surg 2003;51(4):383–9. doi:10.1097/01.SAP.0000067971.90978.8F.
  • Higgins JP, Orlando GS, Blondeel PN. Ischial pressure sore reconstruction using an inferior gluteal artery perforator (IGAP) flap. Br J Plast Surg 2002;55(1):83–5. doi:10.1054/bjps.2001.371.
  • He P, Davis SS, Illum L. In vitro evaluation of the mucoadhesive properties of chitosan microspheres. Int J Pharm 1998;166:75–88. doi:10.1016/s0378-5173(99)00125-8.
  • Goy RC, de Britto D, Assis OBG. A review of the antimicrobial activity of chitosan. Polimeros 2009;19:241–7. doi:10.1590/S0104-14282009000300013.
  • Arbel J, Rozenbaum E, Reges O, Neuman Y, Levi A, Erel J, et al. USage of chitosan for femoral (USF) haemostasis after percutaneous procedures: a comparative open label study. EuroIntervention 2011;6(9):1104–9. doi:10.4244/EIJV6I9A192.
  • Ueno H, Mori T, Fujinaga T. Topical formulations and wound healing applications of chitosan. Adv Drug Deliv Rev 2001;52(2):105–15. doi:10.1016/s0169-409x(01)00189-2.
  • Park CJ, Clark SG, Lichtensteiger CA, Jamison RD, Johnson AJ. Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. Acta Biomater 2009;5(6):1926–36. doi:10.1016/j.actbio.2009.03.002.
  • Azad AK, Sermsintham N, Chandrkrachang S, Stevens WF. Chitosan membrane as a wound-healing dressing: characterization and clinical application. J Biomed Mater Res B Appl Biomater 2004;69(2):216–22. doi:10.1002/jbm.b.30000.
  • VandeVord PJ, Matthew HW, DeSilva SP, Mayton L, Wu B, Wooley PH. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002;59(3):585–90. doi:10.1002/jbm.1270.
  • Usami Y, Minami S, Okamoto Y, Matsuhashi A, Shigemasa Y. Influence of chain length of N-acetyl-d-glucosamine and d-glucosamine residues on direct and complement-mediated chemotactic activities for canine polymorphonuclear cells. Carbohydr Polym 1997;32(2):115–22. doi:10.1016/S0144-8617(96)00153-1.
  • Tsuji S, Ichioka S, Sekiya N, Nakatsuka T. Analysis of ischemia-reperfusion injury in a microcirculatory model of pressure ulcers. Wound Repair Regen 2005;13(2):209–15. doi:10.1111/j.1067-1927.2005.130213.x.
  • Diegelmann RF. Excessive neutrophils characterize chronic pressure ulcers. Wound Repair Regen 2003;11(6):490–5. doi:10.1046/j.1524-475x.2003.11617.x.
  • McGee GS, Davidson JM, Buckley A, Sommer A, Woodward SC, Aquino AM, et al. Recombinant basic fibroblast growth factor accelerates wound healing. J Surg Res 1988;45(1):145–53. doi:10.1016/0022-4804(88)90034-0.
  • Campani V, Pagnozzi E, Mataro I, Mayol L, Perna A, D’Urso F, et al. Chitosan gel to treat pressure ulcers: a clinical pilot study. Pharmaceutics 2018;10(1):15–7. doi:10.3390/pharmaceutics10010015.
  • Mo X, Cen J, Gibson E, Wang R, Percival SL. An open multicenter comparative randomized clinical study on chitosan. Wound Repair Regen 2015;23(4):518–24. doi:10.1111/wrr.12298.
  • Margolis DJ, Cohen JH. Management of chronic venous leg ulcers: a literature-guided approach. Clin Dermatol 1994;12(1):19–26. doi:10.1016/0738-081x(94)90253-4.
  • Ananthanarayanan B, Kim Y, Kumar S. Elucidating the mechanobiology of malignant brain tumors using a brain matrix-mimetic hyaluronic acid hydrogel platform. Biomaterials 2011;32(31):7913–23. doi:10.1016/j.biomaterials.2011.07.005.
  • Weigel PH, Fuller GM, LeBoeuf RD. A model for the role of hyaluronic acid and fibrin in the early events during the inflammatory response and wound healing. J Theor Biol 1986;119(2):219–34. doi:10.1016/s0022-5193(86)80076-5.
  • You HJ, Han SK, Rhie JW. Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers. J Wound Care 2014;23(11):521–30. doi:10.12968/jowc.2014.23.11.521.
  • Fino P, Onesti MG, Felli A, Scuderi N. Clinical examination and treatment of a leg ulcer caused by a stingray puncture. Int J Low Extrem Wounds 2015;14(2):183–6. doi:10.1177/1534734614536037.
  • Beniamino P, Vadalà M, Laurino C. Cross-linked hyaluronic acid in pressure ulcer prevention. J Wound Care. 2016;25(7):400–5. doi:10.12968/jowc.2016.25.7.400.
  • Rossi S, Mori M, Vigani B, Bonferoni MC, Sandri G, Riva F, et al. A novel dressing for the combined delivery of platelet lysate and vancomycin hydrochloride to chronic skin ulcers: hyaluronic acid particles in alginate matrices. Eur J Pharm Sci 2018;118:87–95. doi:10.1016/j.ejps.2018.03.024.
  • Anitua E, Alonso R, Girbau C, Aguirre JJ, Muruzabal F, Orive G. Antibacterial effect of plasma rich in growth factors (PRGF®-Endoret®) against Staphylococcus aureus and Staphylococcus epidermidis strains. Clin Exp Dermatol 2012;37(6):652–7. doi:10.1111/j.1365-2230.2011.04303.x.
  • Ramos-Torrecillas J, García-Martínez O, De Luna-Bertos E, Ocaña-Peinado FM, Ruiz C. Effectiveness of platelet-rich plasma and hyaluronic acid for the treatment and care of pressure ulcers. Biol Res Nurs 2015;17(2):152–8. doi:10.1177/1099800414535840.
  • Kundu B, Rajkhowa R, Kundu SC, Wang X. Silk fibroin biomaterials for tissue regenerations. Adv Drug Deliv Rev 2013;65(4):457–70. doi:10.1016/j.addr.2012.09.043.
  • Thurber AE, Omenetto FG, Kaplan DL. In vivo bioresponses to silk proteins. Biomaterials 2015;71:145–57. doi:10.1016/j.biomaterials.2015.08.039.
  • Min BM, Lee G, Kim SH, Nam YS, Lee TS, Park WH. Electrospinning of silk fibroin nanofibers and its effect on the adhesion and spreading of normal human keratinocytes and fibroblasts in vitro. Biomaterials 2004;25(7–8):1289–97. doi:10.1016/j.biomaterials.2003.08.045.
  • Seo SR, Lee MS, So BP, Kim JC. In vivo pressure sore-healing efficacy of β-cyclodextrin/polyethylenimine/silk fibroin xerogel. Int J Dermatol 2012;51(8):987–95. doi:10.1111/j.1365-4632.2011.05389.x.
  • Reyzelman A, Crews RT, Moore JC, Moore L, Mukker JS, Offutt S, et al. Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J 2009;6(3):196–208. doi:10.1111/j.1742-481X.2009.00585.x.
  • Brigido SA. The use of an acellular dermal regenerative tissue matrix in the treatment of lower extremity wounds: a prospective 16-week pilot study. Int Wound J 2006;3(3):181–7. doi:10.1111/j.1742-481X.2006.00209.x.
  • Jeon M, Kim SY. Application of a paste-type acellular dermal matrix for coverage of chronic ulcerative wounds. Arch Plast Surg 2018;45(6):564–71. doi:10.5999/aps.2018.00605.
  • Strauss NH, Brietstein RJ. Fetal bovine dermal repair scaffold used for the treatment of difficult-to- heal complex wounds. Wounds 2012;24(11):327–34. PMID: 25876169.
  • Golla D, Kurtz Phelan DH. Stage IV perineal pressure ulcers in immobile patients treated with surgical flap closure augmented with cryopreserved placental membrane containing viable cells. Wounds 2019;31(1):15–8. PMID: 30620708.
  • Suzuki K, Michael G, Tamire Y. Viable intact cryopreserved human placental membrane for a non-surgical approach to closure in complex wounds. J Wound Care 2016;25(Sup10):S25–31. doi:10.12968/jowc.2016.25.Sup10.S25.
  • Dehghani M, Azarpira N, Mohammad Karimi V, Mossayebi H, Esfandiari E. Grafting with cryopreserved amniotic membrane versus conservative wound care in treatment of pressure ulcers: a randomized clinical trial. Bull Emerg Trauma 2017;5(4):249–58. doi:10.18869/acadpub.beat.5.4.452.
  • Garoufalis M, Nagesh D, Sanchez PJ, Lenz R, Park SJ, Ruff JG, et al. Use of dehydrated Human amnion/Chorion membrane allografts in more than 100 patients with Six major types of refractory Nonhealing wounds. J Am Podiatr Med Assoc 2018;108(2):84–9. doi:10.7547/17-039.
  • Berhane CC, Brantley K, Williams S, Sutton E, Kappy C. An evaluation of dehydrated human amnion/chorion membrane allografts for pressure ulcer treatment: a case series. J Wound Care 2019;28(Sup5):S4–S10. doi:10.12968/jowc.2019.28.Sup5.S4.
  • Sharma V, Kohli N, Moulding D, Afolabi H, Hook L, Mason C, García-Gareta E. Design of a novel two-component hybrid dermal scaffold for the treatment of pressure sores. Macromol Biosci 2017;17(11):10. doi:10.1002/mabi.201700185.
  • Sun H, Lv H, Qiu F, Sun D, Gao Y, Chen N, et al. Clinical application of a 3D-printed scaffold in chronic wound treatment: a case series. J Wound Care 2018;27(5):262–71. doi:10.12968/jowc.2018.27.5.262.
  • Feldman DS, McCauley JF. Mesenchymal stem cells and transforming growth factor-β3 (TGF-β3) to enhance the regenerative ability of an albumin scaffold in full thickness wound healing. J Funct Biomater 2018;9(4):65. doi:10.3390/jfb9040065.
  • Kilic Bektas C, Kimiz I, Sendemir A, Hasirci V, Hasirci N. A bilayer scaffold prepared from collagen and carboxymethyl cellulose for skin tissue engineering applications. J Biomater Sci Polym Ed 2018;29(14):1764–84. doi:10.1080/09205063.2018.1498718.
  • Ribeiro J, Pereira T, Amorim I, Caseiro AR, Lopes MA, Lima J, et al. Cell therapy with human MSCs isolated from the umbilical cord Wharton jelly associated to a PVA membrane in the treatment of chronic skin wounds. Int J Med Sci 2014;11(10):979–87. doi:10.7150/ijms.9139.
  • Kuroyanagi Y, Yamada N, Yamashita R, Uchinuma E. Tissue-engineered product: allogeneic cultured dermal substitute composed of spongy collagen with fibroblasts. Artif Organs 2001;25(3):180–6. doi:10.1046/j.1525-1594.2001.025003180.x.
  • De Francesco F, Graziano A, Trovato L, Ceccarelli G, Romano M, Marcarelli M, et al. A regenerative approach with dermal micrografts in the treatment of chronic ulcers [published correction appears in Stem Cell Rev. 2017 Feb;13(1):149]. Stem Cell Rev Rep. 2017;13(1):139–48. doi:10.1007/s12015-016-9692-2.
  • Falanga V, Iwamoto S, Chartier M, Yufit T, Butmarc J, Kouttab N, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng 2007;13(6):1299–312. doi:10.1089/ten.2006.0278.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.